Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma (Q34614377)

3 August 2017

Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma (English)

1 reference

3 August 2017

1 reference

1 reference

9

Andrew Berchuck

1 reference

3 August 2017

Louis A Dainty

1

1 reference

3 August 2017

John I Risinger

2

1 reference

3 August 2017

Carl Morrison

3

1 reference

3 August 2017

G V R Chandramouli

4

1 reference

3 August 2017

Michael A Bidus

5

1 reference

3 August 2017

Chris Zahn

6

1 reference

3 August 2017

G Scott Rose

7

1 reference

3 August 2017

Jeff Fowler

8

1 reference

3 August 2017

G Larry Maxwell

10

1 reference

3 August 2017

language of work or name

English

0 references

publication date

2 April 2007

1 reference

3 August 2017

1 reference

3 August 2017

105

1 reference

3 August 2017

563-570

1 reference

3 August 2017

3

1 reference

Folate, DNA methylation, and gene expression: factors of nature and nurture

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Overexpression of folate binding protein in ovarian cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Distribution of OV-TL 3 and MOv18 in normal and malignant ovarian tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Correlation of cyclooxygenase-2 (COX-2) and aromatase expression in human endometrial cancer: tissue microarray analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

A step further in understanding the biology of the folate receptor in ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Folate receptor-targeted drugs for cancer and inflammatory diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Uptake and trafficking of fluorescent conjugates of folic acid in intact kidney determined using intravital two-photon microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Ovarian cancer-associated lymphocyte recognition of folate binding protein peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Why there are two cyclooxygenase isozymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

Expression of prostaglandin G/H synthase type 1, but not type 2, in human ovarian adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.10.063

10.1016/J.YGYNO.2006.10.063

7 January 2021

Identifiers

DOI

1 reference

release_22fzzzdqyff6vly2zaf764cn24

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/22fzzzdqyff6vly2zaf764cn24

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference